Atropine Dosing for Cholinesterase Inhibitor Toxicity

ورودی‌های بالینی بیمار

حداقل ۰.۱ — حداکثر ۳۰۰ • واحد: kg

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
dosing recommendation
—mg
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

Direct Clinical Answer

The Atropine Dosing for Cholinesterase Inhibitor Toxicity calculates assessing acute poisoning severity, antidote indications, and fatal toxicity trajectory. Key inputs include patient type. Scores guide administering specific antidote therapy, gastrointestinal decontamination, and continuous telemetry monitoring. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Doses atropine for cholinesterase inhibitor toxicity from prescription drugs, nerve gas, or insecticides

Clinical Indication

The Atropine Dosing for Cholinesterase Inhibitor Toxicity is indicated for bedside clinical practice to support Doses atropine for cholinesterase inhibitor toxicity from prescription drugs, nerve gas, or insecticides. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with acute pharmaceutical overdose, agricultural pesticide ingestion, toxic gas inhalation, or venomous envenomation. Clinical application is indicated across Poison control centers, acute toxicology wards, emergency resuscitation rooms, and intensive care.

Limitations & Contraindications

Initial serum concentrations for sustained-release or co-ingested anticholinergic agents may falsely appear low before delayed absorption peaks.

Clinical Pearls & Action Plan

Rapid clinical toxidrome identification guides immediate antidote administration; do not wait for confirmatory toxicology assays.

Formula & Variables:

Initial dose: Pediatric = 0.02 mg/kg (up to adult max); Adult mild = 1-2 mg; Adult severe = 3-5 mg. Double dose every 5 minutes until atropinization achieved. Continuous infusion = 10% of total initial doses per hour.

Input Parameters

NameTypeRequiredDescription
patient_typestringYesPatient age category
weightfloatNoPatient weight (required for pediatric patients)(kg)
severitystringYesSeverity of cholinesterase inhibitor toxicity

Evidence-Based References (EBM)

  • Howland MA. Antidotes in Depth: Atropine. In: Hoffman RS, Howland MA, Lewin NA, Nelson LS, Goldfrank LR, eds. Goldfrank's Toxicologic Emergencies. 10th ed. New York, NY: McGraw-Hill; 2015.
  • Abedin MJ, Sayeed AA, Basher A, Maude RJ, Hoque G, Faiz MA. Open-label randomized clinical trial of atropine bolus injection versus incremental boluses plus infusion for organophosphate poisoning in Bangladesh. Clin Toxicol (Phila). 2012 Jun;50(5):433-40.
  • Eddleston M, Dawson A, Karalliedde L, Dissanayake W, Hittarage A, Azher S, et al. Early management after self-poisoning with an organophosphorus or carbamate pesticide - a treatment protocol for junior doctors. Crit Care. 2004 Dec;8(6):R391-7.

Related calculators